Effects of 8 Weeks of Turmeric Ingestion on Physiology and Wellbeing in Healthy Older Adults
NCT ID: NCT07196514
Last Updated: 2026-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
80 participants
INTERVENTIONAL
2025-10-06
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Curcumin Bioavailability
NCT03530436
Oral Bioavailability of Curcumin From Micronized Powder and Liquid Micelles in Healthy Young Women and Men
NCT01925287
Bioavailability of Curcumin Capsules in Healthy Adult Subjects
NCT04972045
Effects of Curcumin on Markers of Cardiovascular Risk in Patients With CAD
NCT04458116
A Study to Compare the Pharmacokinetic Profile of a Proprietary Curcumin Forumulation to a Comparator Curcumin Product
NCT02474953
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
This group will take one placebo shot (containing a small amount of turmeric for taste-matching purposes) twice per day for 8 weeks.
Placebo
This group will take one placebo shot (containing a small amount of turmeric for taste-matching purposes) twice per day for 8 weeks.
Turmeric
This group will take one 60 mL commercially-available shot (containing 30% turmeric) twice per day for 8 weeks.
Raw turmeric shots
This group will take one 60 mL commercially-available shot (containing 30% turmeric) twice per day for 8 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Raw turmeric shots
This group will take one 60 mL commercially-available shot (containing 30% turmeric) twice per day for 8 weeks.
Placebo
This group will take one placebo shot (containing a small amount of turmeric for taste-matching purposes) twice per day for 8 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Diagnosed with diabetes.
* Diagnosed with a liver, lung, or kidney disease.
* Diagnosed with osteoporosis.
* Diagnosed with dementia.
* Diagnosed with cancer.
* Use of medications/supplements/herbal remedies with human evidence of a significant interaction with turmeric.
* Allergy to turmeric, lemon, black pepper, watermelon, water, pineapple, magnesium or vitamin C.
* Pregnant, attempting to become pregnant, or breastfeeding.
* Regular (once per week or more) use of turmeric shots / supplements within the last 3 months.
40 Years
95 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Innate-Essence Limited
UNKNOWN
Nottingham Trent University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
John Hough
Associate Professor in Health and Immunology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Nottingham Trent University, Clifton campus
Nottingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2268061
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.